NCT00139204 Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients Status COMPLETED Phase NA
NCT00139191 Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer Status COMPLETED Phase NA
NCT00137852 Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer Status COMPLETED Phase PHASE2
NCT00137839 Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung Status COMPLETED Phase PHASE2
NCT00137826 Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma Status COMPLETED Phase PHASE2
NCT00137800 Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients Status COMPLETED Phase PHASE2
NCT00137774 Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors Status COMPLETED Phase PHASE2
NCT00137761 Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00136539 Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer Status COMPLETED Phase PHASE2
NCT00136487 Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00136461 A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2
NCT00136448 High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML) Status COMPLETED Phase PHASE2
NCT00136435 A Study in Adults With Untreated Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00136422 Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia Status COMPLETED Phase PHASE1
NCT00136409 A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) Status COMPLETED Phase PHASE2
NCT00136396 Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease Status COMPLETED Phase PHASE1/PHASE2
NCT00134706 A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00134654 Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer Status COMPLETED Phase PHASE2